High-resolution Dosimetry Research Articles

Review on high spatial resolution dosimetry with pixelated semiconductor detectors for radiation therapy

Current and emerging radiation therapy treatment techniques are characterized by complex and spatially non-uniform dose distributions with steep dose gradients delivered through high-precision dose placement with small radiation fields. Such approaches necessitate advanced verification tools. For accurate dose profile representation in stereotactic radiation therapy using megavoltage X-rays, the Nyquist theorem places the minimum sampling step as 2.5 mm that determines the required spatial resolution of the detectors for dose verification. For techniques such as micro- and mini-beam radiotherapy, micron-scale sampling is required, and sub-millimeter for particle therapy. Silicon semiconductor detectors provide the possibility of producing small sensitive volumes (including in arrays) without compromising mechanical robustness or sensitivity, therefore allowing for high spatial resolution dosimetry. They exhibit many properties of an ideal detector, while the properties of silicon detectors known to negatively influence response can be compensated for and minimized. As such, this work reviews the current status of semiconductor radiation detectors providing dose sampling by diodes with submillimeter sensitive volumes and a pitch of 2.5 mm or smaller for relative dosimetry in X-ray and electron external beam radiation therapy, brachytherapy, microbeam radiation therapy, proton, and heavy ion therapy. The following types of devices are discussed in this work, including commercial systems and those under development: one-dimensional and two-dimensional pixelated arrays (monolithic and single diode based).

Comprehensive dosimetric commissioning of proton minibeam radiotherapy on a single gantry proton system.

Proton minibeam radiation therapy (pMBRT) can deliver spatially fractionated dose distributions with submillimeter resolution. These dose distributions exhibit significant heterogeneity in both depth and lateral directions. Accurate characterization of pMBRT doses requires dosimetry devices with high spatial resolution and a wide dynamic range. Furthermore, the dependency of dosimetric measurements on Linear Energy Transfer (LET), as observed in conventional proton therapy, is also present in pMBRT depth dose measurements. This work demonstrates the process of performing comprehensive dosimetric measurements to characterize the pMBRT collimator on a clinical single-gantry proton machine, utilizing commercially available dosimetry devices. The minibeam collimator is designed to be mounted on the clinical nozzle as a beam-modifying accessory. Three collimators, each with a slit opening of 0.4 mm, are thoroughly evaluated. The center-to-center (c-t-c) distances of the slits for these collimators are 2.8 mm, 3.2 mm, and 4.0 mm, respectively. High spatial resolution dosimetry devices are essential for PMBRT dose characterizations. To meet this requirement, two-dimensional (2D) dose measurement devices, Gafchromic films, are used to measure lateral profiles at various depths. Films are also used for depth dose profile measurements in solid water. Additionally, high-resolution point dose detectors, microDiamond, and Razor diode detectors are employed for lateral profile measurements at various depths. Percent depth dose (PDD) measurements of pMBRT in solid water, with various proton energies, collimators, and air gaps, are performed using Gafchromic films. The film's LET dependency for proton beams is corrected to ensure accurate pMBRT PDD measurements. The Monte Carlo simulation tool TOPAS is utilized to compare and validate all experimental measurements. At depths where LET is not a concern, film dose measurements were consistent with microDiamond and Razor diode point measurements. The point detectors need to be orientated with the thin side aligned to the incoming beam. Comparison of the lateral dose profiles extracted from TOPAS simulations, films, microDiamond, and Razor diode detectors shows a passing rate exceeding 98% in 1D gamma analysis at 3% 0.1 mm criteria.However, when the microDiamond detector is orientated to face the pMBRT beam, its spatial resolution may not be sufficient to capture the peak and valley dose accurately. Nevertheless, an accuracy within 2% can still be achieved when comparing the average dose. The PDD measurements show that the peak valley dose ratio (PVDR) of pMBRT can be altered at different depths with different air gaps using the same collimator or different collimators of different c-t-c distances. Our study demonstrates that comprehensive dose measurements for pMBRT can be conducted using standard clinical dose measurement devices. These measurements are indispensable for guiding and ensuring accurate dose reporting in pre-clinical studies using the pMBRT technique.

A review of small animal dosimetry techniques: image-guided and spatially fractionated therapy

Research in small animal radiotherapy is a crucial step in clinical translation of novel radiotherapy techniques, either delivered as stand-alone treatment or in combination with other treatments, such as chemotherapy and immunotherapy. In order to efficiently translate preclinical findings to the clinical setting, preclinical radiotherapy must replicate clinical therapy in terms of mode of delivery as well as dose delivery accuracy as closely as possible. In this review article, we focused on the description of dosimetry tools for radiotherapy of small animals delivered with kilovoltage x-ray beams on image-guided irradiators and in a spatially-fractionated manner by means of microbeam therapy. The specifics of dosimetry of kilovoltage x-ray beam deliveries with small, often sub-millimeter, beams are highlighted, and suitable dosimeters, phantoms, and dose measurement and calculation techniques are reviewed. Future directions for accurate real-time high spatial resolution dosimetry of small animal irradiations are also discussed.

Study of a plastic scintillating plate-based quality assurance system for pencil beam scanning proton beams.

The purpose of this study was to evaluate a plastic scintillating plate-based beam monitoring system to perform quality assurance (QA) measurements in pencil beam scanning proton beam. Single spots and scanned fields were measured with the high-resolution dosimetry system, consisting of a plastic scintillation plate coupled to a camera in a dark box at the isocenter. The measurements were taken at 110-190 MeV beam energies with 30° gantry angle intervals at each energy. Spot positions were determined using the plastic scintillating plate-based dosimetry system at the isocenter for 70-230 MeV beam energies with 30° gantry angle intervals. The effect of gantry angle on dose distribution was also assessed by determining the scanning pattern for daily QA and 25 fields treated with intensity-modulated proton therapy. Spot size, field flatness, and field symmetry of plastic scintillating plate-based dosimetry system were consistent with EBT3 at all investigated energies and angles. In all investigated energies and angles, the spot size measured was ±10% of the average size of each energy, the spot position measured was within ±2 mm, field flatness was within ±2%, and field symmetry was within ±1%. The mean gamma passing rates with the 3%/3 mm gamma criterion of the scanning pattern and 25 fields were 99.2% and 99.8%, respectively. This system can be effective for QA determinations of spot size, spot position, field flatness, and field symmetry over 360° of gantry rotation in a time- and cost-effective manner, with spatial resolution comparable to that of EBT3 film.

High spatial resolution dosimetry with uncertainty analysis using Raman micro-spectroscopy readout of radiochromic films.

The purpose of this work is to develop a new approach for high spatial resolution dosimetry based on Raman micro-spectroscopy scanning of radiochromic film (RCF). The goal is to generate dose calibration curves over an extended dose range from 0 to 50Gy and with improved sensitivity to low (<2Gy) doses, in addition to evaluating the uncertainties in dose estimation associated with the calibration curves. Samples of RCF (EBT3) were irradiated at a broad dose range of 0.03-50Gy using an Elekta Synergy clinical linear accelerator. Raman spectra were acquired with a custom-built Raman micro-spectroscopy setup involving a 500 mW, multimode 785 nm laser focused to a lateral spot diameter of 30µm on the RCF. The depth of focus of 34µm enabled the concurrent collection of Raman spectra from the RCF active layer and the polyester laminate. The preprocessed Raman spectra were normalized to the intensity of the 1614cm-1 Raman peak from the polyester laminate that was unaltered by radiation. The mean intensities and the corresponding standard deviation of the active layer Raman peaks at 696, 1445, and 2060cm-1 were determined for the 150×100µm2 scan area per dose value. This was used to generate three calibration curves that enabled the conversion of the measured Raman intensity to dose values. The experimental, fitting, and total dose uncertainty was determined across the entire dose range for the dosimetry system of Raman micro-spectroscopy and RCF. In contrast to previous work that investigated the Raman response of RCFs using different methods, high resolution in the dose response of the RCF, even down to 0.03Gy, was obtained in this study. The dynamic range of the calibration curves based on all three Raman peaks in the RCF extended up to 50Gy with no saturation. At a spatial resolution of 30×30µm2 , the total uncertainty in estimating dose in the 0.5-50Gy dose range was [6-9]% for all three Raman calibration curves. This consisted of the experimental uncertainty of [5-8]%, and the fitting uncertainty of [2.5-4.5]%. The main contribution to the experimental uncertainty was determined to be from the scan area inhomogeneity which can be readily reduced in future experiments. The fitting uncertainty could be reduced by performing Raman measurements on RCF samples at further intermediate dose values in the high and low dose range. The high spatial resolution experimental dosimetry technique based on Raman micro-spectroscopy and RCF presented here, could become potentially useful for applications in microdosimetry to produce meaningful dose estimates in cellular targets, as well as for applications based on small field dosimetry that involve high dose gradients.

Dose uncertainty and resolution of polymer gel dosimetry using an MRI guided radiation therapy system’s onboard 0.35 T scanner

Magnetic Resonance Imaging (MRI) scanners are widely used for 3D gel dosimeters readout. However, limited access to MRI scanners is a challenge in MRI-based gel dosimetry. Recent clinical implementation of MRI-guided radiation therapy machines provides potential opportunities for onboard gel dosimetry using its MRI subsystem. The objective of this study was to investigate the feasibility of gel dosimetry using ViewRay’s onboard 0.35 T MRI scanner. A BANG® polymer gel dosimeter was irradiated by three beams of 3 × 3 cm2 field size. The T2 relaxation rate (R2) of the irradiated gel was measured using a Philips 1.5 T Ingenia MRI and a ViewRay 0.35 T onboard MRI and spin-echo pulse sequences. The number of signal averages (NSA) was set to 16 for the ViewRay acquisitions and one for the Philips 1.5 T MRI to achieve similar signal-to-noise ratios. The in-plane spatial resolution was 1.5 × 1.5 mm2 and the slice thickness was 5 mm. The relative dose uncertainty was obtained using R2 versus dose curves to compare the performance of dosimetry using the two different MRIs and field strengths. The dose uncertainty decreased from 12% at 2 Gy to 3.5% at 7.5 Gy at 1.5 T. The dose uncertainty decreased from 13% at 2 Gy to 4% at 7.5 Gy with NSA = 16 and 3 × 3 mm2 pixel size, and from 10.5% at 2 Gy to 3.2% at 7.5 Gy with NSA = 16 and denoised R2 maps (1.5 × 1.5 mm2 pixel size) at 0.35 T. The mean of dose resolution was 0.4 Gy at 1.5 T while the mean of dose resolution was 0.8 Gy and 0.64 Gy at 0.35 T by downsampling and denoising the R2 map, respectively. Therefore, comparable dose uncertainty was achievable using the ViewRay’s onboard 0.35 T and Philips 1.5 T MRI scanners. 3D gel dosimetry using onboard low-field MRI scanner provides ViewRay users a 3D high resolution dosimetry option besides film and ionization chamber.

Dose profiles and x-ray energy optimization for microbeam radiation therapy by high-dose, high resolution dosimetry using Sm-doped fluoroaluminate glass plates and Monte Carlo transport simulation

Microbeam radiation therapy (MRT) utilizes highly collimated synchrotron generated x-rays to create narrow planes of high dose radiation for the treatment of tumors. Individual microbeams have a typical width of 30–50 µm and are separated by a distance of 200–500 µm. The dose delivered at the center of the beam is lethal to cells in the microbeam path, on the order of hundreds of Grays (Gy). The tissue between each microbeam is spared and helps aid in the repair of adjacent damaged tissue. Radiation interactions within the peak of the microbeam, such as the photoelectric effect and incoherent (atomic Compton) scattering, cause some dose to be delivered to the valley areas adjacent to the microbeams. As the incident x-ray energy is modified, radiation interactions within a material change and affect the probability of interactions, as well as the directionality and energy of ionizing particles (electrons) that deposit energy in the valley regions surrounding the microbeam peaks. It is crucial that the valley dose between microbeams be minimal to maintain the effectiveness of MRT. Using a monochromatic x-ray source with x-ray energies ranging from 30 to 150 keV, a detailed investigation into the effect of incident x-ray energy on the dose profiles of microbeams was performed using samarium doped fluoroaluminate (FA) glass as the medium. All dosimetric measurements were carried out using a purpose-built fluorescence confocal microscope dosimetric technique that used Sm-doped FA glass plates as the irradiated medium. Dose profiles are measured over a very a wide range of x-ray energies at micrometer resolution and dose distribution in the microbeam are mapped. The measured microbeam profiles at different energies are compared with the MCNP6 radiation transport code, a general transport code which can calculate the energy deposition of electrons as they pass through a given material. The experimentally measured distributions can be used to validate the results for electron energy deposition in fluoroaluminate glass. Code validation is necessary for using transport codes in future treatment planning for MRT and other radiation therapies. It is shown that simulated and measured micro beam-profiles are in good agreement, and micrometer level changes can be observed using this high-resolution dosimetry technique. Full width at 10% of the maximum peak (FW@10%) was used to quantify the microbeam width. Experimental measurements on FA glasses and simulations on the dependence of the FW@10% at various energies are in good agreement. Simulations on energy deposited in water indicate that FW@10% reaches a local minimum around energies 140 keV. In addition, variable slit width experiments were carried out at an incident x-ray energy of 100 keV in order to determine the effect of the narrowing slit width on the delivered peak dose. The microbeam width affects the peak dose, which decreases with the width of the microbeam. Experiments suggest that a typical microbeam width for MRT is likely to be between 20–50 µm based on this work.

First experimental measurement of the effect of cardio-synchronous brain motion on the dose distribution during microbeam radiation therapy.

Microbeam radiation therapy (MRT) is an emerging radiation oncology modality ideal for treating inoperable brain tumors. MRT employs quasi-parallel beams of low-energy x rays produced from modern synchrotrons. A tungsten carbide multislit collimator (MSC) spatially fractionates the broad beam into rectangular beams. In this study, the MSC creates beams 50μm wide ("peaks") separated by a center-to-center distance of 400μm ("valleys"). The peak to valley dose ratio (PVDR) is of critical importance to the efficacy of MRT. The underlying radiobiological advantage of MRT relies on high peak dose for tumor control and low valley dose for healthy tissue sparing. Cardio synchronous brain motion of the order 100-200μm is comparable to microbeam width and spacing. The motion can have a detrimental effect on the PVDR, full width at half maximum (FWHM) of the microbeams, and ultimately the dose distribution. We present the first experimental measurement of the effect of brain motion on MRT dose distribution. Dosimetry in MRT is difficult due to the high dose rate (up to 15-20kGy/s) and small field sizes. A real-time dosimetry system based on a single silicon strip detector (SSSD) has been developed with spatial resolution ~10μm. The SSSD was placed in a water-equivalent phantom and scanned through the microbeam distribution. A monodirectional positioning stage reproduced brain motion during the acquisition. Microbeam profiles were reconstructed from the SSSD and compared with Geant4 simulation and radiochromic HD-V2 film. The SSSD is able to reconstruct dose profiles within 2μm compared to film. When brain motion is applied the SSSD shows a two time increase in FWHM of profiles and 50% reduction in PVDR. This is confirmed by Geant4 and film data. Motion-induced misalignment and distortion of microbeams at treatment delivery will result in a reduced PVDR and increased irradiation of additional healthy tissue compromising the radiobiological effectiveness of MRT. The SSSD was able to reconstruct dose profiles under motion conditions and predict similar effects on FWHM and PVDR as by the simulation. The SSSD is a simple to setup, real-time detector which can provide time-resolved high spatial resolution dosimetry of microbeams in MRT.

Instrumentation for high-dose, high-resolution dosimetry for microbeam radiation therapy using samarium-doped fluoroaluminate and fluorophosphate glass plates

We show that 1% Sm-doped fluoroaluminate (FA) glass plate and a suitably modified fluorescence confocal microscope provide an excellent radiation detection platform for high-dose measurements at high resolution down to the micron scale. We have used a custom-modified fluoroscopic confocal microscope apparatus to scan, separate, detect, and digitize the photoluminescence (PL) signals from Sm3+ and Sm2+ ions in both FA and fluorophosphate (FP) glasses within a selected focal depth of the microscope below the sample surface. The response (R) of Sm-doped FA and FP glass plates to incident x-ray radiation was studied in detail in which R was defined as the difference in the ratio of PL signals from Sm2+ and Sm3+ before and after irradiation. We report on a number of important issues related to the use of these Sm-doped FA and FP glass plates in microbeam radiation therapy (MRT) dosimetry: The dependence of the Sm3+ to Sm2+ conversion, and hence R on the dose rate over some four orders of magnitude; the energy dependence of R at a given dose rate for both FA and FP samples with various concentrations of Sm3+ doping; R versus dose behavior at different energies up to 2000 Gyair and the derivation of the detector calibration curves; the stability of the Sm-doped plates after they have been exposed; the instrumental limits of the present measurement technique.

Investigation of lung tumour peripheral doses using normoxic polymer gel and film dosimetry techniques

This paper describes the investigation of lung tumour peripheral doses for 6MV, 6MV FFF, 10MV FFF and 15MV conformal arc therapy (CAT) beams calculated in the Monaco® TPS and delivered using a flattening filter free capable Elekta® AgilityTM linac. Two independent high resolution dosimetry techniques were used for investigations. Measurements were performed using the normoxic PAG polymer gel dosimeter and GAFchromicTM EBT3 film and compared against the calculated dose plane from the Monaco treatment planning system. Both measurement methodologies indicate that Monaco is overestimating the lung tumour peripheral dose for the beams investigated in this study. It is shown that when using 10MV FFF in lung for arc deliveries, there is a dosimetric compromise compared with 6MV and 6MV FFF.

A new reference-type ionization chamber with direction-independent response for use in small-field photon-beam dosimetry – An experimental and Monte Carlo study

The frequently applied narrow and non-standard transverse dose profiles of intensity modulated photon-beam radiotherapy, lacking lateral secondary electron equilibrium, require the use of high-resolution dosimetry detectors, and small air-filled detectors are recommended as the reference detectors for cross-calibration of the high-resolution detectors. The present study focuses on the dosimetric properties of a novel cylindrical ionization chamber, the PTW Semiflex 3D 31021. The chamber's effective point of measurement was found to lie at (0.41±0.04) r downstream the tip of the inner surface of the spherical front wall in the axial orientation and (0.46±0.04) r upstream the chamber axis in the radial orientation. Due to its symmetrical design, the sigma values of its lateral dose response functions for all chamber's orientations are the same (2.10±0.05mm). The polarity correction factors obtained in this work do not exceed 0.1% and the saturation correction factor was below 1% up to a dose-per-pulse value of 0.956mGy. The radiation quality correction factor kQ of the chamber as a function of the tissue-phantom-ratio, TPR20,10, has been calculated by Monte Carlo simulation and has been determined experimentally at the German Metrology Institute (Physikalisch-Technische Bundesanstalt, PTB). The values of the non-reference condition correction factor kNR have been Monte-Carlo-calculated for use of the chamber at various depths and field sizes.

Characterization of a commercial scintillation detector for 2-D dosimetry in scanned proton and carbon ion beams

IntroductionPencil beam scanning technique used at CNAO requires beam characteristics to be carefully assessed and periodically checked to guarantee patient safety. This study aimed at characterizing the Lynx® detector (IBA Dosimetry) for commissioning and periodic quality assurance (QA) for proton and carbon ion beams, as compared to EBT3 films, currently used for QA checks. Methods and materialsThe Lynx® is a 2-D high-resolution dosimetry system consisting of a scintillating screen coupled with a CCD camera, in a compact light-tight box. The scintillator was preliminarily characterized in terms of short-term stability, linearity with number of particles, image quality and response dependence on iris setting and beam current; Lynx® was then systematically tested against EBT3 films. The detector response dependence on radiation LET was also assessed. ResultsPreliminary results have shown that Lynx is suitable to be used for commissioning and QA checks for proton and carbon ion scanning beams; the cross-check with EBT3 films showed a good agreement between the two detectors, for both single spot and scanned field measurements. The strong LET dependence of the scintillator due to quenching effect makes Lynx® suitable only for relative 2-D dosimetry measurements. ConclusionLynx® appears as a promising tool for commissioning and periodic QA checks for both protons and carbon ion beams. This detector can be used as an alternative of EBT3 films, allowing real-time measurements and analysis, with a significant time sparing.

Micro-Mini & Nano-Dosimetry & Innovative Technologies in Radiation Therapy (MMND&ITRO2016)

The biennial MMND (formerly MMD) - IPCT workshops, founded in collaboration with Memorial Sloan Kettering Cancer Center (MSKCC) in 2001, has become an important international multidisciplinary forum for the discussion of advanced dosimetric technology for radiation therapy quality assurance (QA) and space science, as well as advanced technologies for prostate cancer treatment.In more recent years, the interests of participants and the scope of the workshops have extended far beyond prostate cancer treatment alone to include all aspects of radiation therapy, radiation science and technology. We therefore decided to change the name in 2016 to Innovative Technologies in Radiation Oncology (ITRO). MMND ITRO 2016 was held on 26-31 January, 2016 at the beautiful Wrest Point Hotel in Hobart, Tasmania and attracted an outstanding international faculty and nearly 200 delegates from 18 countries (http://mmnditro2016.com/)The MMND 2016 program continued to cover advanced medical physics aspects of IMRT, IGRT, VMAT, SBRT, MRI LINAC, innovative brachytherapy, and synchrotron MRT. The demand for sophisticated real time and high temporal and spatial resolution (down to the submillimetre scale) dosimetry methods and instrumentation for end–to-end QA for these radiotherapy technologies is increasing. Special attention was paid to the contribution of advanced imaging and the application of nanoscience to the recent improvements in imaging and radiotherapy.The last decade has seen great progress in charged particle therapy technology which has spread throughout the world and attracted strong current interest in Australia. This demands a better understanding of the fundamental aspects of ion interactions with biological tissue and the relative biological effectiveness (RBE) of protons and heavy ions. The further development of computational and experimental micro-and nano-dosimetry for ions has important application in radiobiology based treatment planning and space radiation hazard prediction. New compact accelerator technologies for the delivery of proton and heavy ion therapy and relevant QA dosimetry instrumentation were an additional focus of MMND 2016.The ITRO program this year was dedicated to clinical aspects of innovative SBRT for cancer treatment. It represented a unique opportunity to learn from didactic lectures as well as case based discussions with world leaders in the field in the relaxed atmosphere of Hobart.As well as the outstanding scientific program, MMND ITRO 2016 included an Australian beach BBQ to celebrate Australia Day on the evening of 26th January and an exciting social program on 29th January followed by the conference dinner and great Australian hospitality.The MMND workshop represents an important next step for improving current cancer treatments with radiation and the development of new radiation based cancer treatments.

Dosimetric characterization of a commercial 2-D scintillation detector for quality assurance tests in scanned proton and carbon ion beams

Introduction Pencil beam scanning technique used at CNAO requires beam characteristics to be carefully and periodically checked to guarantee patient safety. Radiochromic films are used within daily QA checks. Purpose This study aimed at characterizing the Lynx PT system (IBA Dosimetry) and assessing its suitability for QA tests, for proton and carbon ion beams. Materials and methods The Lynx PT is a 2D high-resolution dosimetry system consisting of a scintillating screen coupled with a CCD camera, in a compact light-tight box. A dedicated software is used for image acquisition, raw data correction and fast data analysis. Lynx was characterized in terms of short-term stability, image geometrical distortion, uniformity, signal proportionality, response dependence on IRIS and on particle intensity, particle energy and type. Irradiations were performed at the Centro Nazionale di Adroterapia Oncologica (CNAO) for both protons and carbon ions. Measurements with Lynx were compared to those made with EBT3 reference films. The detector response dependence on radiation LET was also investigated. Results Lynx basic characterization results have shown a proportional behavior with delivered number of particles. Strong dependence of the acquired signal on beam energy and particle type was found. No significant differences in the investigated beam parameters measured with Lynx and EBT3 film were observed. The detector also showed good performances in term of image uniformity and geometrical distortion. Conclusion The Lynx PT system appears as a promising tool for measurements for both single pencil beam and scanned beam, enabling fast QA and beam optics optimization checks.

WE‐AB‐BRB‐00: Session in Memory of Robert J. Shalek: High Resolution Dosimetry from 2D to 3D to Real‐Time 3D

Despite widespread IMRT treatments at modern radiation therapy clinics, precise dosimetric commissioning of an IMRT system remains a challenge. In the most recent report from the Radiological Physics Center (RPC), nearly 20% of institutions failed an end‐to‐end test with an anthropomorphic head and neck phantom, a test that has rather lenient dose difference and distance‐to‐agreement criteria of 7% and 4 mm. The RPC report provides strong evidence that IMRT implementation is prone to error and that improved quality assurance tools are required. At the heart of radiation therapy dosimetry is the multidimensional dosimeter. However, due to the limited availability of water‐equivalent dosimetry materials, research and development in this important field is challenging. In this session, we will review a few dosimeter developments that are either in the laboratory phase or in the pre‐commercialization phase. 1) Radiochromic plastic. Novel formulations exhibit light absorbing optical contrast with very little scatter, enabling faster, broad beam optical CT design. 2) Storage phosphor. After irradiation, the dosimetry panels will be read out using a dedicated 2D scanning apparatus in a non‐invasive, electro‐optic manner and immediately restored for further use. 3) Liquid scintillator. Scintillators convert the energy from x‐rays and proton beams into visible light, which can be recorded with a scientific camera (CCD or CMOS) from multiple angles. The 3D shape of the dose distribution can then be reconstructed. 4) Cherenkov emission imaging. Gated intensified imaging allows video‐rate passive detection of Cherenkov emission during radiation therapy with the room lights on. Learning Objectives: To understand the physics of a variety of dosimetry techniques based upon optical imaging To investigate the strategies to overcome respective challenges and limitations To explore novel ideas of dosimeter designSupported in part by NIH Grants R01CA148853, R01CA182450, R01CA109558. Brian Pogue is founder and president of the company DoseOptics LLC, dedicated to developing and commercializing the first dedicated Cerenkov imaging camera and system for radiation dose imaging. Work reported in this talk does not involve the use of DoseOptics technology.; H. Li, this work was supported in part by NIH Grant No. R01CA148853; S. Beddar, NIH funding R01‐CA182450

EP-1501: New material for high resolution dosimetry using radiation induced changes in fluorescence response

EP-1501: New material for high resolution dosimetry using radiation induced changes in fluorescence response

SU‐E‐T‐644: QuAArC: A 3D VMAT QA System Based On Radiochromic Film and Monte Carlo Simulation of Log Files

Purpose:VMAT involves two main sources of uncertainty: one related to the dose calculation accuracy, and the other linked to the continuous delivery of a discrete calculation. The purpose of this work is to present QuAArC, an alternative VMAT QA system to control and potentially reduce these uncertainties.Methods:An automated MC simulation of log files, recorded during VMAT treatment plans delivery, was implemented in order to simulate the actual treatment parameters. The linac head models and the phase‐space data of each Control Point (CP) were simulated using the EGSnrc/BEAMnrc MC code, and the corresponding dose calculation was carried out by means of BEAMDOSE, a DOSXYZnrc code modification. A cylindrical phantom was specifically designed to host films rolled up at different radial distances from the isocenter, for a 3D and continuous dosimetric verification. It also allows axial and/or coronal films and point measurements with several types of ion chambers at different locations. Specific software was developed in MATLAB in order to process and evaluate the dosimetric measurements, which incorporates the analysis of dose distributions, profiles, dose difference maps, and 2D/3D gamma index. It is also possible to obtain the experimental DVH reconstructed on the patient CT, by an optimization method to find the individual contribution corresponding to each CP on the film, taking into account the total measured dose, and the corresponding CP dose calculated by MC.Results:The QuAArC system showed high reproducibility of measurements, and consistency with the results obtained with the commercial system implemented in the verification of the evaluated treatment plans.Conclusion:A VMAT QA system based on MC simulation and high resolution dosimetry with film has been developed for treatment verification. It shows to be useful for the study of the real VMAT capabilities, and also for linac commissioning and evaluation of other verification devices.

WE-AB-BRB-02: Development of a Micro-Sized Dosimeter for Real-Time Dose Monitoring and Small Field Dosimetry

Purpose: To investigate a miniature optical dosimeter for real-time, high-resolution dosimetry, and explore its potential applications for in vivo measurements and small field dosimetry. Methods: A micro-sized hemispherical (400 µm radius) scintillating detector was constructed from lanthanide activated phosphors doped with Europium (GOS:Eu) and encapsulated in a 17 gauge plastic catheter. A photon counting PMT and CCD-chip spectrometer were used to detect signals emitted from the detector. A single band-passing spectral approach (630nm) was implemented to discriminate the micro-phosphor optical signal from background signals (Cerenkov radiation) in the optical fiber. To test real-time monitoring capabilities, a 3D-printed phantom was used to detect an 192Ir HDR brachytherapy source at locations ranging from 1 to 4 cm radially and 12 cm along the travel axis of the HDR wire. To test the application of the micro-sized detector for small field dosimetry, the linearity of detector was characterized through irradiation of 6MV photon beam at dose-rates ranging from 100 to 600 MU, and the effect of field size was characterized through detections of beams ranging from 30×30 to 1×1 cm2 size. Results: With a 1 second integration time for the spectrometer, the recorded measurements indicated that the micro-sized detector allowed accurate detection of source position at distances of up to 6 cm along the axis of travel in water. EB measurements showed that the detected signal was linearly correlated with dose rate (R^2 = 0.99). The crossbeam profile was determined with a step size of ∼500 µm. Conclusion: Miniaturization of optical dosimeters is shown to be possible through the construction of lanthanide activated doped phosphors detectors. The small size of the detector makes it amenable to a variety of applications, including real-time dose delivery verification during HDR brachytherapy and EB beam calibrations in small fields.

WE-AB-BRB-05: Toward a 2D Water-Equivalent Dosimetry Panel Using KCl:Eu2+

Purpose: KCl:Eu2+ storage phosphor shows promise for radiation therapy dosimetry. The purpose of this work is to investigate several important aspects of this material for potential commercial use. Methods: KCl:Eu2+ chips were fabricated and a conformal coating using Parylene was applied. Material’s dose response in a 6 MV beam was investigated using Monte-Carlo simulations. We attempted to micronize the materials using a spiral jet mill. As we did not have a water-free glovebox, we used commercially available non-hygroscopic BaFBr0.85I0.15:Eu2+ computed radiography material to test if a homogeneous panel can be made using micron-sized phosphors. Results: Dosimeters remained intact and showed no change in PSL intensity after eight hrs of submersion in water. We then optically bleached the samples for reuse, irradiated and immersed for another 24 hrs. We observed marginal worsening of the PSL signal for both the soaked and un-soaked chips. By contrast, we were unable to measure PSL intensity of the un-coated pellets due to these pellets dissolving within minutes of being immersed in water. MC data indicate that the micron-sized KCl:Eu2+ is predicted to have a nearly water-equivalent response. KCl:Eu2+ particles with a median size of 3 microns can be produced using a jet mill, which could be reduced further if necessary. While the particles tend to agglomerate over time when stored in a desiccator, they still possess favorable d50’s and d99’s even after 100 minutes, providing an adequate time window for making a panel via tape casting. A panel cast using optimized methods exhibits nearly perfect particle arrangement. Conclusions: Data shown here support ongoing efforts in fabricating a reusable, high resolution dosimetry panel in a water-free glovebox using micron-sized KCl:Eu2+ particles separated by water-equivalent polymers. The conformal coating thereafter will provide good humidity resistance. HL is the founder of DoseImaging, LLC that is exclusively dedicated to commercializing this technology.

Surface dose characterisation of the Varian Ir-192 HDR conical surface applicator set with a vertically orientated source.

Conical surface applicators with an Ir-192 high-dose-rate brachytherapy source are a common modality for the treatment of non-melanomatous skin cancer with high tumour control rates. Surface dose characterisation of the Varian Varisource GammaMed+ IX afterloader vertical type surface applicators is performed two dimensionally using high-resolution film dosimetry. The focus of this study was to determine if Varian surface applicators with a vertical source suffer from the dose distribution irregularities reported for comparable applicators. Our goal was to evaluate if the irregularities found affected treatment and dose output verification procedures. Ionisation chamber-based verification of applicator output was established according to guidelines provided by the manufacturer. For additional measurement of surface dose Gafchromic EBT3 film dosimetry was used. The term "therapeutic dose" was defined as 85% of the prescribed dose level. For the 10 different applicator inserts evaluated, cold spots were observed. Mean cold spot size was 2.0 mm × 3.6 mm (± 0.6 mm). The cold spots were dosimetrically well below 85% of the prescribed dose. The cold spot was situated 2.2 mm (1.4-2.7 mm) unilaterally from the central axis and caused general asymmetry in the dose profiles intersecting the cold spot area. A source tilt of approximately 8° (± 1°) was determined for the source used for irradiation. A central underdosed area exceeding 15 % of the prescribed dose has not been previously reported. Source tilt was observed and found to affect clinical use and possibly treatment outcome in applicators using a vertically arranged source. Surface applicators with a vertically orientated source were subject to dose irregularities that could impact on chamber-based applicator output verification procedures. We recommend film dosimetry-backed applicator commissioning to avoid systematic errors.